Jolanda M Smit Selected Research

Infections

11/2023	Mitochondrial protein BNIP3 regulates Chikungunya virus replication in the early stages of infection.
6/2023	Characterization of soluble TLR2 and CD14 levels during acute dengue virus infection.
10/2022	TLR2 axis on peripheral blood mononuclear cells regulates inflammatory responses to non-infectious immature dengue virus particles.
1/2022	Vitamin D-induced LL-37 modulates innate immune responses of human primary macrophages during DENV-2 infection.
1/2022	Mediators of Obesity Do Not Influence SARS-CoV-2 Infection or Activation of Primary Human Lung Microvascular Endothelial Cells In Vitro.
11/2021	Tomatidine reduces Chikungunya virus progeny release by controlling viral protein expression.
10/2021	Resveratrol and Pterostilbene Inhibit SARS-CoV-2 Replication in Air-Liquid Interface Cultured Human Primary Bronchial Epithelial Cells.
10/2021	Regulation of innate immune responses in macrophages differentiated in the presence of vitamin D and infected with dengue virus 2.
1/2020	Suramin Inhibits Chikungunya Virus Replication by Interacting with Virions and Blocking the Early Steps of Infection.
1/2020	Serotonergic Drugs Inhibit Chikungunya Virus Infection at Different Stages of the Cell Entry Pathway.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jolanda M Smit Research Topics

Disease

39	Infections 11/2023 - 06/2002
10	Dengue (Dengue Fever) 06/2023 - 12/2009
6	Virus Diseases (Viral Diseases) 02/2024 - 03/2005
5	Severe Dengue 06/2023 - 01/2012
3	COVID-19 01/2022 - 10/2021
3	Coinfection 06/2017 - 10/2013
1	Inflammation (Inflammations) 02/2024
1	Disease Progression 06/2023
1	Aspergillosis 01/2022
1	Candidiasis (Moniliasis) 01/2022
1	Obesity 01/2022
1	Critical Illness (Critically Ill) 01/2022
1	Mosquito-Borne Diseases 01/2020
1	Chikungunya Fever 01/2020
1	Reinfection 01/2014
1	Flavivirus Infections 01/2013
1	Neuroblastoma 06/2002

Drug/Important Bio-Agent (IBA)

11	Antiviral Agents (Antivirals)IBA 01/2022 - 01/2013
11	AntibodiesIBA 01/2016 - 01/2009
4	VaccinesIBA 01/2020 - 07/2015
4	CytokinesIBA 10/2017 - 01/2013
3	Proteins (Proteins, Gene)FDA Link 11/2023 - 05/2009
3	tomatidineIBA 11/2021 - 01/2019
2	Peptide Hydrolases (Proteases)FDA Link 02/2024 - 12/2009
2	Viral ProteinsIBA 01/2022 - 11/2021
2	Vitamin D FDA LinkGeneric 01/2022 - 10/2017
2	RNA (Ribonucleic Acid)IBA 11/2021 - 10/2017
2	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2021 - 01/2013
2	Glycoproteins (Glycoprotein)IBA 01/2020 - 06/2002
2	Monoclonal AntibodiesIBA 01/2013 - 05/2009
2	FurinIBA 01/2012 - 11/2011
2	Liposomes (Liposome)IBA 12/2009 - 06/2002
1	Protease Inhibitors (Protease Inhibitor)IBA 02/2024
1	Cell Surface ReceptorsIBA 02/2024
1	ProteomeIBA 11/2023
1	Small Interfering RNA (siRNA)IBA 11/2023
1	Mitochondrial Proteins (Mitochondrial Protein)IBA 11/2023
1	Lipopolysaccharide ReceptorsIBA 06/2023
1	Biomarkers (Surrogate Marker)IBA 06/2023
1	Toll-Like Receptor 2IBA 10/2022
1	moxidectinIBA 01/2022
1	posaconazole FDA Link 01/2022
1	Ivermectin (Mectizan)FDA Link 01/2022
1	LeptinIBA 01/2022
1	AdipokinesIBA 01/2022
1	Viral RNAIBA 11/2021
1	AntioxidantsIBA 10/2021
1	ResveratrolIBA 10/2021
1	pterostilbeneIBA 10/2021
1	Serotonin AgentsIBA 01/2020
1	5-nonyloxytryptamineIBA 01/2020
1	Serotonin Receptor Agonists (Serotonin Receptor Agonist)IBA 01/2020
1	Suramin (Suramin Sodium)IBA 01/2020
1	Serotonin ReceptorsIBA 01/2020
1	Cholecalciferol (Vitamin D3)FDA Link 10/2017
1	Adenosine DeaminaseIBA 10/2017
1	Mannose ReceptorIBA 10/2017
1	Interleukin-10 (Interleukin 10)IBA 10/2017
1	VitaminsIBA 10/2017
1	MicroRNAs (MicroRNA)IBA 10/2017
1	Interleukin-4 (Interleukin 4)IBA 10/2017
1	Interleukin-8 (Interleukin 8)IBA 06/2017
1	Interleukin-6 (Interleukin 6)IBA 06/2017
1	3' Untranslated Regions (3' UTR)IBA 01/2016
1	Blocking AntibodiesIBA 01/2016
1	ChemokinesIBA 01/2016
1	HLA-DR Antigens (HLA-DR)IBA 01/2016
1	Neutralizing AntibodiesIBA 01/2016
1	EpitopesIBA 01/2015
1	Dengue VaccinesIBA 01/2015
1	DC-specific ICAM-3 grabbing nonintegrin (DC-SIGN)IBA 01/2014
1	Doxorubicin (Adriamycin)FDA LinkGeneric 10/2013
1	LCTA-949IBA 01/2012
1	TrypsinIBA 12/2009
1	Virus ReceptorsIBA 03/2005
1	LactoferrinIBA 03/2005
1	LipidsIBA 06/2002

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2013